This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
In PM360 ‘s article, What Is Pharma Marketing in 2025 ? Applied AI Although AI promises a great return on investment, the pharma industry has been slow to adopt it due to ethical, regulatory, and compliance hurdles. Angela suggests that organizations should prioritize educating and experimenting with AI.
Understanding the new EU Clinical Trial Regulation: seven things sponsors should know Historically, to gain regulatory approval to run a clinical trial, sponsors have needed to submit clinical trial applications separately to national competent authorities (NCAs) and ethics committees in each country.
The world of pharma marketing is changing rapidly, and 2025 will be no exception. So, what will be the top challenges in 2025, and how can pharma marketers tackle them? Data Privacy and Compliance Challenges Data privacy is one of the most pressing concerns in 2025, especially with new regulations being enacted globally.
Malaysia’s Budget 2025 is out, on October 18th 2024, and it’s packed with changes that will touch nearly every aspect of your lives and mine, from salaries to taxes, and even our environment. Now, before you celebrate, this change kicks in February 2025, so we have to wait a bit. Boosting Wages (Finally!) What about you?
Whats in store for 2025? Unlike previous years where five to seven trends were examined, the 2025 report narrowed its focus to three that matter most and will make the most impact across the pharma landscape this year: applied AI, the Direct-to-Patient (DTP) model, as well as globalization and health equity.
Its sustainability platform, fueled by its Health for Humanity 2025 Goals, contributes to the global effort to achieve a majority of the SDGs by supporting 11 of the 17, spanning the spheres of global health, social justice, environmental stewardship, and responsible business practices. Ethics is a skill.” Why make it inviting?
As we approach 2025, emerging trends are reshaping how the industry engages with patients and healthcare providers. Adhering to guidelines from the FDA and other governing bodies ensures that campaigns remain effective without crossing ethical boundaries. Navigating these requires a fine balance between creativity and compliance.
In 2025, pharmaceutical trends are redefining how brands connect with healthcare professionals (HCPs), patients, and stakeholders. Regulatory bodies like the FDA and EMA enforce stringent advertising guidelines, ensuring that pharma companies maintain transparency and ethical marketing practices.
In 2025, pharma marketing news is filled with innovation, disruption, and opportunities to grow your business. In 2025, digital channels dominate marketing strategies as companies shift from traditional campaigns to online platforms. What are the biggest challenges in pharma marketing in 2025?
As we approach 2025, the pharmaceutical industry is witnessing a seismic shift in marketing strategies, driven by technological advancements and evolving consumer expectations. However, the rise of influencer partnerships also necessitates careful consideration of ethical and regulatory guidelines.
As we move into 2025, the integration of advanced analytics within CRM software and systems is not just a luxuryit is a necessity. Best Practices for CRM Analytics in 2025 Given these trends, how can organizations optimize their CRM analytics strategies for 2025 and beyond? Here are some key recommendations: 1.
February 20, 2025 Danvers, Mass. Oliver Patel , AI Governance Lead at AstraZeneca , and Roanie Levy , former CEO and President of Access Copyright , will discuss building a responsible and ethical AI governance program, navigating risks, and maximizing trust and value from innovation.
As such, working with a provider with extensive experience in gamification , including familiarity with compliance and ethical and regulatory guidelines, is a must. Medical Education in 2025 and BeyondWhere does Gamification Fit in?
marketers, we have an ethical duty to position purposeful marketing initiatives not only for the insured American, but for humanity. In pharma, we get the chance to do that as we all fight for health equity in 2025 and beyond. Global thinking needs to be better applied everywhere. If it were easy, wed all be doing it.
This article explores top strategies that can help you lead with confidence and achieve executive success in 2025. Make sure everyone understands the legal and ethical boundaries of marketing in pharma. As a pharma marketing executive, your ability to adapt and innovate will define your success in 2025 and beyond.
In medcomms, AIs future lies not only in its technological advancements but also in how creatively and ethically it is applied. By addressing these hurdles proactively, the industry can position itself as a leader in ethical AI use and innovation.
Starting in 2025, health technology assessment (HTA) experts from across Europe will join forces to produce joint clinical assessment (JCA) reports, which will be used to support national health economic assessments as well as inform pricing and reimbursement discussions. A more flexible approach is needed.
For] AI use in life sciences R&D… 2025 will see the industry enter the “plateau of enlightenment” AI use in life sciences R&D has now passed through most major stages of the Gartner Hype Cycle 2 and 2025 will see the industry enter the “plateau of enlightenment.” Computers in Biology and Medicine.
According to GlobalData, global AI revenues in the pharmaceutical, medical, and healthcare sectors are expected to reach almost $21 billion by 2025. GlobalData is the parent company of Pharmaceutical Technology.
Most importantly, it gives more power to already influential tech giants and puts focus on the commercialization of biohacks rather than their health consequences or ethics. billion by 2025. Thus, we can see the technocratic rule of this age and the pervasiveness of tech hustle culture as driving biohacking.
But lets be real, 2025 is not playing around. The Struggles Are Real: Challenges in Ramadhan 2025 1.1 Hustling Smart: Sales Strategies for Ramadhan 2025 2.1 Apply this work ethic beyond Ramadhan to become a sharper, more efficient sales rep. Tough sales reps do." MOs and pharmacists ghosting you till after Raya.
January 7, 2025 Danvers, Mass. As General Counsel for Cambridge University Press & Assessment, Sheret manages a large global team responsible for legal, business ethics and compliance, brand, community engagement, and sustainability.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content